Landau DA, Carter SL, Stojanov P, et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell. 2013;152(4):714-26. doi:10.1016/j.cell.2013.01.019
Hett EC, Slater LH, Mark KG, et al. Chemical genetics reveals a kinase-independent role for protein kinase R in pyroptosis. Nat Chem Biol. 2013;9(6):398-405. doi:10.1038/nchembio.1236
Guttman M, Russell P, Ingolia NT, Weissman JS, Lander ES. Ribosome profiling provides evidence that large noncoding RNAs do not encode proteins. Cell. 2013;154(1):240-51. doi:10.1016/j.cell.2013.06.009
Cheng CS, Rai K, Garber M, et al. Semiconductor-based DNA sequencing of histone modification states. Nat Commun. 2013;4:2672. doi:10.1038/ncomms3672
Shen RR, Zhou AY, Kim E, et al. TRAF2 is an NF-κB-activating oncogene in epithelial cancers. Oncogene. 2015;34(2):209-16. doi:10.1038/onc.2013.543
Necsulea A, Soumillon M, Warnefors M, et al. The evolution of lncRNA repertoires and expression patterns in tetrapods. Nature. 2014;505(7485):635-40. doi:10.1038/nature12943
Carter AC, Davis-Dusenbery BN, Koszka K, Ichida JK, Eggan K. Nanog-independent reprogramming to iPSCs with canonical factors. Stem Cell Reports. 2014;2(2):119-26. doi:10.1016/j.stemcr.2013.12.010
Bavelloni A, Piazzi M, Raffini M, Faenza I, Blalock WL. Prohibitin 2: At a communications crossroads. IUBMB Life. 2015;67(4):239-54. doi:10.1002/iub.1366
Jiang L, Wallerman O, Younis S, et al. ZBED6 modulates the transcription of myogenic genes in mouse myoblast cells. PLoS One. 2014;9(4):e94187. doi:10.1371/journal.pone.0094187
Gong Y, Zack TI, Morris LGT, et al. Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins. Nat Genet. 2014;46(6):588-94. doi:10.1038/ng.2981